A Study of Prescribing Pattern in Patients of Hypertension

##plugins.themes.academic_pro.article.sidebar##

Published Jul 11, 2019
https://doi.org/10.18311/ijmds/2019/23418
Download
PDF
Statistic

Downloads

Download data is not yet available.
Volume 8, Issue 2, July 2019

##plugins.themes.academic_pro.article.main##

Faiziul Haq
Junior Resident, Department of Pharmacology, GMC Patiala, 147001, Punjab
Harinder Singh
Ex Professor, Department of Pharmacology, GMC Patiala, 147001, Punjab
Vijay K. Sehgal
Professor and Head, Department of Pharmacology, GMC Patiala, 147001, Punjab
Sanjeev Kumar
Professor, Department of Medicine, GMC Patiala, 147001, Punjab
Anjleen Kaur
Assistant Professor, Department of Pharmacology, GMC Patiala, 147001, Punjab

Abstract

Introduction: Hypertension is a multi-factorial and complex disease that has both environmental and genetic determinants. It is the single most significant risk factor for heart diseases and kidney diseases. Hypertension is a leading contributor to global burden of morbidity and mortality. It is considered as a silent killer because most of the time it is asymptomatic and goes undetected. Hence, hypertensive patients should be prescribed properly. Objectives: To evaluate the prescribing pattern of anti-hypertensive drugs in patients of hypertension. Material and Methods: This was an observational, cross sectional study conducted over a period of 1 year on hypertensive patients attending the Cardiology out-patient department of Government Medical College and Rajindra Hospital, Patiala and fulfilling the inclusion and exclusion criteria. The prescriptions were evaluated. Results: 22% of prescriptions had monotherapy, amongst which beta-blockers were most commonly prescribed. Majority of prescriptions had two drug therapy (47%), among which ARB+ beta blockers (17%) were most frequently prescribed. Beta blockers +CCB (9%) was the most common Fixed Drug Combination (FDC) prescribed. ARB+beta blockers+diuretics (14%) and ACEI+ARB+beta blockers+diuretics (1%) were most commonly prescribed three drug combinations. Among four drug combinations, only ACEI+ARB+beta blockers+diuretics was prescribed to 1% patients. Hypolipidemic drugs (66%) were maximally co-prescribed. Conclusions: A high trend of polypharmacy was observed in hypertensive patients. So, emphasis is needed to reevaluate the prescribing trends in these patients.

##plugins.themes.academic_pro.article.details##

How to Cite
Haq, F., Singh, H., Sehgal, V. K., Kumar, S., & Kaur, A. (2019). A Study of Prescribing Pattern in Patients of Hypertension. International Journal of Medical and Dental Sciences, 1759–1765. https://doi.org/10.18311/ijmds/2019/23418
Crossref
Scopus
Google Scholar
Europe PMC

References

  1. Artham SM, Lavie CJ, Milani RV, Ventura HO. Obesity and Hypertension, Heart Failure, and Coronary Heart DiseaseRisk Factor, Paradox, and Recommendations for Weight Loss. The Ochsner Journal. 2009; 9:124–32. PMid:21603427 PMCid:PMC3096264
  2. Benjamin EJ, Virani SS, Callaway CW, Cheng AR, Cheng S, Chiuve SE, et al., on behalf of the American Heart Association council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics -2018 update: A report from the American Heart Association [ published online ahead of print January 31, 2018]. Circulation DOI:10.1161/CIR.0000000000000558
  3. Hypertension: The silent killer. Indian Council of Medical Research. Department of Health Research- Ministry of Health and Family Welfare. Available from: https://www.icmr.nic.in/sites/default/files/press_realease_files/ Hypertension.pdf
  4. Gupta R, Mohan I, Narula J. Trends in coronary heart disease epidemiology in India. Ann Glob Health. 2016; 82:307–15. https://doi.org/10.1016/j.aogh.2016.04.002 PMid:27372534
  5. A global brief on Hypertension. Silent Killer, global public health crisis. World Health Day 2013. Geneva, Switzerland. Available from: http://ish-world.com/downloads/pdf/ global brief hypertension.pdf
  6. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL et al. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure; the JNC report. JAMA. 2003; 289(19):2560–72. https://doi.org/10.1001/ jama.289.19.2560 PMid:12748199
  7. Gupta R, Yusuf S. Towards better hypertension management in India. Indian J Med Res. 2014;139(5):657– 60. PMid:25027073 PMCid:PMC4140027
  8. Sharma AK, Dahiya N, Kairi JK, Bharati SM. Prescription patterns of antihypertensive drugs in a tertiary care hospital in India. Int J Basic Clin Pharmacol. 2015; 4(1):55–9.
  9. https://doi.org/10.5455/2319-2003.ijbcp20150208
  10. Roobiya A, Ranjith J. Prescription pattern and patient counselling of hypertention patients in a tertiary care hospital. International Journal of Innovative Research and Advanced Studies. 2018 Jan; 5(1):242–55.
  11. Jhawat V, Gupta S, Agarwal BK, Saini V. Comparison of the prescription pattern of antihypertensive drug therapy over time and its association with severity of essential hypertension. Int J Pharma Res Health Sci. 2017; 5(6):1994–8.
  12. Khurshid F, Aqil M, Alam MS, Kapur P, Pillai KK. Antihypertensive Medication Prescribing Patterns in a University Teaching Hospital in South Delhi. Int J Pharm Sci Res. 2012; 3(7):2057–63.
  13. Sutters M. Systemic hypertension. In: Papadakis MA, McPhee SJ, Rabow MW, editors. Current Medical Diagnosis and Treatment. 52nded. New York: McGraw Hill; 2013. p. 433–63.
  14. Cidda M, Mateti UV, Batchu MK, Martha S. Study of prescribing patterns of antihypertensives in South Indian population. Int J Basic Clin Pharmacol. 2014; 3(2):303–7.
  15. https://doi.org/10.5455/2319-2003.ijbcp20140409
  16. Panja M, Mondal S, Bhattacharya P, Mondal D. Beta Blocker in Combination with Other Antihypertensives. Supplement of JAPI. 2009; 57:35–7.
  17. Murti K, Khan MA, Dey A, Sethi MK, Das P, Pandey K. Prescription pattern of anti-hypertensive drugs in adherence to JNC- 7 guidelines. American Journal of Pharmacology and Toxicology. 2015; 10(1):27–31. https://doi.org/10.3844/ajptsp.2015.27.31
  18. Cidda M, Mateti UV, Batchu MK, Martha S. Study of prescribing patterns of antihypertensives in South Indian population. Int J Basic Clin Pharmacol. 2014; 3(2):303–7.
  19. https://doi.org/10.5455/2319-2003.ijbcp20140409
  20. Tandon VR, Sharma S, Mahajan S, Mahajan A, Khajuria V, Mahajan V, et al. Antihypertensive drug prescription patterns, rationality, and adherence to Joint National Committee-7 hypertension treatment guidelines among Indian postmenopausal women. J Mid-life Health. 2014; 5:78–83. https://doi.org/10.4103/0976-7800.133994 PMid:24970986 PMCid:PMC4071649
  21. Beg MA, Dutta S, Varma A, Kant R, Bawa S, Anjoom M, et al. A study on drug prescribing pattern in hypertensive patients in a tertiary care teaching hospital at Dehradun, Uttarakhand. Int J Med Sci Public Health. 2014; 3(8):922–6. https://doi.org/10.5455/ijmsph.2014.170420146

Most read articles by the same author(s)